Amylx Pharmaceuticals Inc vs Shopify Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Shopify Inc. trades at $150.34 (market cap $196.35B). The key difference: Shopify Inc. is far larger — about 74.4× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals.
| AMLX | SHOP | |
|---|---|---|
Market Cap | $2.64B | $196.35B |
Sector | Health | Technology |
52-Week High | $24.19 | $179.01 |
52-Week Low | $7.82 | $95.40 |
Enterprise Value | $2.39B | $191.59B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Shopify (SHOP) trades at $155.18, up 2.38% today, following strong Q2 2026 earnings beats. The stock exhibits a bullish technical trend with support at $151 and resistance at $158. Revenue growth remains robust, with 2025 revenue reaching $11.56B, though valuation multiples like a P/E of 103.11 are elevated. Positive analyst sentiment is driven by AI commerce integration and expanding gross merchandise volume.
Outlook is positive given earnings momentum and AI-driven growth, but high valuation and competitive e-commerce pressures pose risks. The consensus price target of $166.39 suggests modest upside, supported by 65.62% of analysts rating it Buy. Investors should weigh growth prospects against premium pricing.
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →